PRLD - Prelude Therapeutics Incorporated - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

93.6M

Cash

172.3M

Avg Qtr Burn

-22.99M

Short % of Float

33.82%

Insider Ownership

7.43%

Institutional Own.

77.18%

Qtr Updated

03/31/23

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
PRT811 (PRMT5 inhibitor) Details Glioblastoma, Cancer, primary central nervous system lymphomas	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PRT543 (PRMT5 inhibitor) Details Solid tumor/s, Myelodysplastic syndrome, Myelofibrosis, Cancer	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PRT1419 (MCL1 inhibitor) Details Myelodysplastic syndrome, Non-Hodgkin lymphoma, Acute myeloid leukemia, Multiple myeloma	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PRT2527 (CDK9 inhibitor) Details Myelodysplastic syndrome, Non-Hodgkin lymphoma, Acute myeloid leukemia, Multiple myeloma	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PRT3645 (CDK4/6 inhibitor) Details Glioblastoma, Head and neck cancer, Non-small cell lung carcinoma, Breast cancer	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.